VES-001

N/A

Report date: 2025/11/03 13:48:13
NMEFirst In Class

Base Information

Drug NameVES-001
Drug Alias NameVES-001VES001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSortilin inhibitors
TargetsSortilin
Therapy Area/IndicationsFrontotemporal DementiaFrontotemporal Lobar DegenerationDementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsDenmarkUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVesper Bio APS
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsFrontotemporal DementiaFrontotemporal Lobar DegenerationDementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A